Cardiovascular anesthesiologists once stood at the top of anesthesia practices, often leading groups and earning the highest compensation due to their specialized training. Today, declining case volumes, reimbursement pressures and subsidy reductions have eroded their exceptional status.
A September 8 blog post by Coronis Health explores the shifting landscape of cardiovascular anesthesia and what it means for practices.
Here are four takeaways:
1. From prominence to parity
Historically, cardiovascular anesthesiologists held leadership roles and commanded top pay, thanks to their fellowship training, board certification, and demanding cardiac call schedules. Now, their elevated status has faded, with many practices treating them on par with other anesthesiologists.
2. Case volumes are stable or declining
Coronary artery bypass grafting (CABG) cases across Coronis Health client practices have remained relatively consistent in recent years, with some practices seeing declines. Despite the complexity of these cases, they only account for about 1% of total practice revenue.
3. Revenue potential has diminished
Most CABG cases are reimbursed at Medicare rates, limiting their financial contribution. Even with the use of arterial lines, Swan-Ganz catheters, and TEEs, the revenue per case is only slightly above surgical averages, making it less lucrative for practices to justify premium pay for cardiac-trained anesthesiologists.
4. Cardiac call stipends under pressure
With revenue and facility subsidies insufficient to support higher compensation, cardiac call stipends have become the main lever for additional pay. Yet as hospitals tighten budgets and reduce subsidies, stipends are increasingly at risk, further flattening compensation across providers.
Practices now view cardiovascular anesthesia as less of a premium specialty and more as a standard component of anesthesia services, with compensation aligning accordingly.
